Confirming the efficacy and broader potential of their smartphone-based diagnostic app, ResApp Health Limited (ASX: RAP) clinical data referenced in a top academic publication has validated their app’s accuracy for respiratory diagnostics. Data from their Breathe Easy adult clinical study has been published in a peer-reviewed Nature partner journal, npj Digital Medicine. The study looked
Read More
Australians that are struggling to get a good night sleep can now screen their likelihood of suffering from sleep apnoea with medtech company ResApp Health (ASX: RAP) having launched their clinically tested SleepCheck app on the iPhone App Store. By downloading the smartphone app, SleepCheck can record and analyse breaking and snorting sounds during sleep
Read More
Med-tech developer ResApp Health (ASX: RAP) has received certification from European regulators for the world’s first smartphone-based respiratory diagnostics test. ResAppDx-EU is a mobile app which can be used by medical clinicians to diagnose respiratory conditions including tract disease, croup, pneumonia, asthma and bronchiolitis. “We are very excited about receiving our first regulatory approval for
Read More